Charles River Laboratories | CRL - Interest Income


Charles River Laboratories reported $-0.03 in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
Agilent USD 13M 2M Mar/2026
Align Technology USD 3.91M 710K Mar/2026
Bio-Rad Laboratories USD 22.3M 1.3M Jun/2026
Bruker USD 15.3M 10.9M Jun/2026
Charles River Laboratories USD -0.03 0.27 Jun/2026
Concord Medical Services Hldg CNY 5.8M 659K Jun/2023
Danaher USD 1.23 27M Jun/2026
Dentsply International USD 4M 1000K Mar/2025
Illumina USD 1.35 0.48 Jun/2026
Incyte USD 38.12M 4.43M Jun/2026
Intrexon USD 319K 602K Jun/2024
IQVIA Holdings USD 7M 3M Jun/2026
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Merck EUR 36M 15M Mar/2026
Pfizer USD -0.04 115M Jun/2026
Quest Diagnostics USD 2M 1000K Mar/2026
Revvity USD 6.3M 552K Mar/2026
Thermo Fisher Scientific USD 233M 25M Mar/2026
United Therapeutics USD 31.5M 10.3M Jun/2026
Veradigm USD 1.7M 1.6M Sep/2022
Waters USD 6M 331K Mar/2026
West Pharmaceutical Services USD 5.1M 0 Mar/2026